PerkinElmer Unveils Reagent Platforms.

PerkinElmer, Inc. (45 William St., Wellesley, MA; Tel: 781/237- 5100) has unveiled three new reagent technologies for drug discovery screening: DELFIA GTP Binding Assay kit, the first non- radiometric platform for guanosine triphosphate (GTP) binding; Image FlashPlate, a new red-emission technology for a wide range of high throughput screening (HTS) imagers; and britelite and steadylite HTS, breakthrough luminescence technologies for G- protein coupled receptor (GPCR) functional screening applications.

PerkinElmer says DELFIA GTP Binding Assay is the first non- radiometric assay kit that screens for GTP binding, offering customers the industry's only alternative to …